HB Partner Webinars on the West LegalEdcenter
Take these CLE webinars on the West LegalEdcenter platform. Each program features leading litigators in their respective fields on emerging subjects. Speakers and topics are handpicked by HB. Your organization may have already subscribed to the platform, but each session is also available for individual purpose. For questions or if you wish to propose a webinar, write to us at: Webinars@LitigationConferences.com.
Blockchain: Power to the People
Dan Solove, co-founder of the Privacy+Security Forum and professor at GW Law School, just posted an interview with Steve Shillingford, Founder and CEO of Anonyome Labs, a consumer privacy software company. Below is part of just one exchange in the interview. SOLOVE: The Internet has made so many things possible that we couldn’t do in an analog world. Yet, in some ways, the online world seems to lack the capabilities of the offline world. In the offline world, it is much easier to have anonymous transactions. This becomes much more challenging online. How can the online world be made more like the offline world in this regard? SHILLINGFORD: Blockchain technology shifts the balance of power back to people—to individuals—and away from tech giants, governments and data miners. It allows you to transact on your terms, just as you do offline. And it’s not just limited to financial transactions. Put anything on the blockchain you want. The blockchain gives a person the ability to publish only the information THEY decide to divulge. Nothing more, nothing less. And no more hidden agendas, no selling personal data without your consent, no worries about privacy. Just like the analogue world, you decide the context, the content, and duration of the information you provide…not the big guys. It can really be that easy. Read the complete interview. See the latest faculty and agenda updates for the Privacy+Security Forum 2018 | Oct. 3-5, 2018 | Washington, D.C.
Oracle Health Sciences on Pharmacovigilance and Artificial Intelligence
"The potential to use artificial intelligence methods increasingly for the analysis of the increasing amounts of pharmacovigilance data is well understood and many companies are moving (or planning to move) there, and we can predict that routine tasks in pharmacovigilance will in the future be increasingly automated. It will be crucial, however, for regulatory authorities to very clearly provide a position about the use of AI as well as the acceptable level of quality from AI applications. But in parallel with the shaping of those definitions, given the massive increase in their AE case workloads that most companies are currently experiencing, the industry will out of necessity proceed swiftly with the adoption of AI and cloud technologies to reduce their costs and increase their efficiencies. "Like other industries, the pharmaceutical business and in particular the pharmacovigilance field will see a massive change in their processes in the near future, away from tedious, repetitive manual tasks towards a better utilization of scarce resources, in particular medical and scientific knowledge, for value-adding tasks. It is imperative for all stakeholders – industry, service providers and regulators – to provide an environment in which such a transformation can take place without ever compromising public health or the safety of the individual patient, and ideally providing additional benefit for patients." A quote from Addressing the Data Challenges of Pharmacovigilance Download the paper from Oracle Health Sciences We are covering this subject at: Drug & Device Defense Forum | Oct. 15, 2018 | New York
Artificial Intelligence in the Drug and Device Industries
Are Data Divers and Miners Going to Lead Innovation? The big tech companies are into it. Apple, IBM and Google. Roche is into it. Medtronic, as well. Artificial intelligence has been a big part of innovation in the healthcare space for several years, and its impact is only going to get bigger. "Artificial intelligence-based healthcare technologies have contributed to improved drug discoveries, tumor identification, diagnosis, risk assessments, electronic health records (EHR), and mental health tools, among others," writes Blank Rome attorney Brian Higgins in his Artificial Intelligence and the Law Blog (it's excellent, by the way). [1] Daniel Faggella of TechEmergence.com writes that machine learning healthcare applications are getting a lot of attention in the press and from the investment community. He adds to the list of machine learning's impact things like treatment queries and suggestions, and even robotic surgery. But optimism for AI's application to drug discovery seems greater than that inspired by other healthcare sectors. One reason for that, Faggella writes, is that compared to other segments where various laws and stakeholder incentives may not align, "drug discovery stands out as a relatively straightforward economic value for machine learning healthcare application creators." He adds that this application also involves "one relatively clear customer who happens to generally have deep pockets: drug companies." [2] Also writing for TechEmergence.com, Kumba Sennaa says doctors may feel threatened at the idea of competing with artificial intelligence tools. Not so in the case of drug makers. "Unlike doctors, pharma companies have every reason in the world to adopt the most cutting-edge technologies in the expensive and lengthy process of drug discovery," Sennaa writes. "Unlike other applications within healthcare facilities, drug discovery seems to have a clearer path to adoption." [3] AI-fueled innovation is, in turn, fueled by data. Lots and lots of data. [...]
Courtney Klein on Social Media & Security
A Restructured Paradigm for Corporate Teamwork By Courtney Klein of Soteria Risk Consultants Social media has become an integral part of everyday life. It’s how some of us get our news, research our opinions, learn about local events, and connect with friends. For the modern western business, it is also immensely important for staying in touch with customers, advertising, and overall visibility. For this reason, many companies employ veritable armies of “Social Media Specialists” that do everything from designing graphics to writing tweets to replying to customer questions and complaints. Some companies interact with each other (such as the hilarious and long-standing Twitter Battle between Wendy’s and McDonald's), and some use it as their primary form of communication. Customers, too, know that social media is a way to get in touch with a company - for good reasons and for bad - and while many companies are aware that they will and do receive threats on social media, very few of them have any kind of protocol in place for how to deal with them – and even fewer still encourage their social media teams to pass this information on to or (better yet) work together with their security team. This sort of blasé attitude to threats – either because “it’s not my job” or “they can’t be serious” – leads to real-world ramifications. Incidents such as the April 4th Youtube Shootings (which, we acknowledge, was a failure of many different departments, companies, and law enforcement operations) are a reminder of just how social media “banter” can turn into a real-world nightmare. Now, in defense of essentially any company guilty of this, Social Media is a new beast that even the best are still trying to get their arms wrapped around. Not only is social media relatively new to the game, but [...]
Francoise Gilbert on Colorado’s New Privacy Law: Are You Ready?
Effective Sept. 1, 2018, Colorado will require all entities that process or store certain personal information of Colorado residents, regardless of whether the entity is located within or outside of Colorado, to have formal data security and data disposal programs. This is the result of the adoption of Bill 18-1128 “Concerning Strengthening Provisions for Consumer Data Privacy,” signed into law at the end of May 2018, to amend and supplement existing law .... Previously, the definition of “personal identifying information” under the Colorado law was limited to a resident’s first name or initial and last name in combination with the individual’s Social Security, driver’s license, or identification card number, or a credit or debit card or bank account number, combined with a password or access code. The new definition includes additional forms of identification, such as student, military, passport, and health insurance identification number, as well as other types of information, such as medical information or biometric data. It also includes username or e-email address in combination with a password or security question answers that would permit access to an online account .... Organizations that collect personal identifying information of Colorado residents and that do not yet have the written programs necessary to formalize their data protection practices urgently need to focus on compliance. -- Francoise Gilbert, Greenberg Traurig Francoise Gilbert, a partner at Greenberg Traurig, is the author of the two volume treatise “Global Privacy and Security Law” (Wolters Kluwer Publishing), covering 68 countries. Her practice has focused on information privacy and security for more than 25 years. She advises clients on the entire spectrum of domestic and international privacy and cyber security issues legal issues, such as Internet of Things, smart cities, artificial intelligence, analytics, digital advertising and other cutting-edge developments that rely on the extensive use of personal [...]
A.I. Best Practices: Rules and Policies for Using Artificial Intelligence in Your Business
Explore how cybersecurity breaches impact insurance, risk management, and data privacy with evolving legal and compliance challenges. [one-third-first] DATE: Sept. 27, 2018 TIME: 2 p.m. EDT; 1 p.m. CDT; 12 p.m. MDT; 11 a.m. PDT PLACE: Your computer or mobile device PRICE: $197* per dial-in site *Price is good through Aug. 16. After that it's $247. GROUPS ARE GOOD: Registering qualifies you to multiple attendees at your location. CLE: 1 credit Please send CLE questions to CLE@LitigationConferences.com SPEAKER: John Frank Weaver Attorney McLane Middleton Your registration includes: • A site license to attend this webinar (invite as many people in one location as you can fit around your computer at no extra charge). • Downloadable PowerPoint presentations from our speakers. • The opportunity to connect directly with speakers during the audience Q&A session. • At least one-hour of CLE credit. Produced in collaboration with and their new Journal of Robotics, Artificial Intelligence & Law [/one-third-first] [two-thirds] Nearly every industry is adopting or preparing to adopt artificial intelligence applications into their business practices. That's exciting. However, there are almost no government regulations for their use and few resources providing best practices that anticipate ethical considerations and forthcoming legal requirements. This lack of direction poses a serious problem as A.I. applications become more widespread. Businesses are creating their own ad hoc practices without considering the eventual government oversight and ethical consensus, which will result in costs and potential liability later when those companies have to change their practices. This webinar looks at how your company should approach its A.I. rules and policies in order to minimize the impact of expected government action and cultural norms. Register now and join our speaker as he explores existing laws addressing privacy and data security, pending A.I. legislation at the state and federal levels, and the recommendations [...]
McLoughlin on Artificial Intelligence in Banking
"Capital adequacy requirements are not the only kind of regulation that AI is helping banks to meet. An even bigger area is monitoring of trading activities for misconduct and abuse. The Bank of England estimates that misconduct by traders has cost banks a global cumulative of $320 billion to date. For this very large reason, banks are aggressively deploying machine learning to monitor the behavior of their traders and detect unusual behavior." Read Michael McLoughlin's post on LinkedIn. Michael McLoughlin is Global Digital Transformation Partner & Advocate with Microsoft.
Joshua Gold on Cyber Crime and Insurance
With the amount of trickery going into thefts and embezzlements these days, crime insurance companies too often use the many steps involved in a fraudulent scheme to argue that losses are indirect and otherwise uncovered. The recent decisions of the Second Circuit and Sixth Circuit on the “direct loss” argument and the scope of computer fraud coverage are important victories for policyholders generally, making clear that where the predominant step in the chain is some type of covered fraudulent misconduct involving a computer, a court is not going to entertain a direct loss defense to excuse the insurance company from paying. As such, policyholders should be familiar with their crime coverage and promptly notify all potentially implicated lines of insurance coverage when a cybercriminal is afoot. -- Joshua Gold, Anderson Kill Read Josh's complete article. Joshua Gold is Chair of Anderson Kill’s Cyber Insurance Recovery Practice and was amicus counsel for United Policyholders in the Medidata Solutions, Inc. v. Federal Insurance Company case before the Second Circuit.
Halligan, Weyland on Cybersecurity, Trade Secret Asset Management and the Defend Trade Secret Act of 2016
"Cybersecurity protection against outsider theft has largely succeeded, if competently crafted business methods are strictly followed. The more intractable problem of insider theft is now the major concern, and traditional cybersecurity methods are unavailing. The ever-higher digital barriers placed around the corporation and its sensitive data are no defense against data theft by people allowed inside the digital walls in the normal course of business." Read their complete post on LinkedIn. R. Mark Halligan is a Partner and Trial Lawyer at FisherBroyles, LLP. Mr. Halligan has taught Advanced Trade Secrets Law in the John Marshall Law School LLM program for 24 years. Richard F. Weyand is the President of the Trade Secret Office, Inc. www.thetso.com See R. Mark Halligan and Richard F. Weyand Trade Secret Asset Management 2018: A Guide to Information and Asset Management Including RICO and Blockchainavailable on Amazon. https://www.amazon.com/dp/0997070986
Willis Towers Watson: Cyber Risk Top D&O Concern
Based on their survey, Willis Towers Watson says cyber risk continues to top the list of concerns for directors and officers (right up there with employee claims). As for coverage, while they care about price, things like their relationship with the carriers and how well they handle claims are critical elements. And, maybe one key reason cyber events keep happening: "Only 13% of board members feel that their organizations learn from past cyber mistakes." Read the results of the Willis Towers Watson survey.
RSA’s Zulfikar Ramzan on Blockchain
Is blockchain as impenetrable as people think? Or as necessary? It's not predicated on the same type of cryptographic security that we've seen historically, but if someone has enough money and enough motivation -- like a nation state -- couldn't they severely compromise a system? Is blockchain the only way transactional protections can become so secure, or could traditional technologies be employed and with less effort? RSA Security's Chief Technology Officer Zulfikar Ramzan, Ph.D., spoke at our Cyber Sector Risk: Blockchain Security in April 2018 in New York. Hear what he had to say about this much-heralded technology. Related content https://litigationconferences.com/www-litigationconferences-comprivacysecurity-forum-2018-2/ https://litigationconferences.com/international-cyber-risk-management-conference/ https://litigationconferences.com/video-the-urgency-of-cyber-threats-to-u-s-and-global-critical-infrastructures/
Right to Try Act: Commentary Roundup
A Life Saver, Political Grandstand, or Harmful Scam? Depends on Who You Ask. And When. It's been two months since President Donald J. Trump signed into law the Right to Try Act which allows terminally ill patients access to experimental drugs not yet approved by the FDA. Like many things in America in 2018, opinions on the efficacy of this new law vary along party or ideological lines. Will it give hope and precious life-extending solutions for patients fighting terminal disease? Or is it a money-driven scheme intended to enrich corporations and the super rich? Signed into law on May 24, 2018, is it something that can be implemented effectively? Here are a few quotes that explain the controversy. Additional commentary or insights welcome. Send yours to Editor@LitigationConferences.com. "Timely access to promising treatments in ... devastating circumstances." "This new law amends the Federal Food, Drug, and Cosmetic Act to establish a new pathway aimed at increasing access to unapproved, investigational treatments for patients diagnosed with life-threatening diseases or conditions who have exhausted approved treatment options and who are unable to participate in a clinical trial. Our implementation of the Right to Try Act will build on our long-standing efforts to help patients and families who are facing life-threatening diseases or conditions, in a way that seeks to protect their autonomy, their safety, and the safety of others following in their paths." "The decisions we reach related to products that can serve as an effective treatment for a terminal illness, or that can arrest a devastating and debilitating condition, are among the most important and carefully considered judgments that we make. We recognize the important balance between making sure patients have the assurances Congress intends, while enabling timely access to promising treatments in these devastating circumstances. And we’ll implement [...]
Judy Selby on Improving Cyber and Privacy Board Reporting
"While general awareness of cyber risks among corporate boards is increasing, even the most motivated and knowledgeable directors cannot effectively fulfill their duties without receiving appropriate data about the organization’s risk profile. Unfortunately, however, there appears to be a disconnect between management and boards when it comes to cyber risk reporting . . . In order for directors to effectively discharge their duty of active, informed, and engaged oversight, the information they receive must be relevant, understandable, reliable, and objective." Judy Selby, JD Judy Selby Consulting Read the full article and Judy's tips for improving board reporting. Judy Selby of Judy Selby Consulting
BitSight Releases eBook on Use of A.I. & Big Data in Continuous Cyber Risk Monitoring
"With every reported data breach or cyberattack, the cyber risk landscape gets a little more complex. Cyber criminals create new attack vectors, cybersecurity professionals develop new controls to protect their systems, the criminals get to work circumventing the controls, and so on.The result of this back and forth is that cyber risk professionals have a huge variety of risk factors to worry about. In response, risk managers and security specialists need to develop extremely complex cybersecurity programs to make sure all of their bases are covered. "With so many cybersecurity risks to consider, it’s inevitable that some will receive less attention than they deserve. Unfortunately, these overlooked risk factors could play a role in your next cyberattack, and if your financial services firm isn’t prepared, that could be extremely costly." Read more. We're looking forward to seeing the BitSight team in Bermuda Dec. 6-7, 2018, at the International Cyber Risk Management Conference.
Crowell & Moring on Insurance for Autonomous Vehicles Accidents
"As responsibility for accidents shifts away from drivers and towards the companies that design, manufacture, and maintain autonomous vehicles, the pool of companies potentially liable for accidents will deepen.Companies need to consider potential liability risk when designing autonomous vehicle-related systems and partnering with other companies." Another good piece from the team Crowell & Moring LLP
Crowell & Moring on D&O Corporate Liability for Cyber Claims
"Although many commentators have noted the potential exposure for cyber claims in the form of shareholder actions under D&O coverage, little attention has been given to the risks of cyber exposure under Side C [D&O corporate liability] coverage," write Laura A. Foggan and Thomas Kinney of Crowell & Moring LLP. "D&O policies contain many exclusions and coverage limitations that should protect against undue, unintended expansion of such policies to encompass cyber risks. However, as this case illustrates, courts may not always agree that those coverage limitations fully address cyber breach exposures."
CBD: Confusing Regulations May Soon Find at Least Some Clarity — But Proceed With Caution
By Tom Hagy July 16, 2018 Proponents say the medical benefits are many and magnificent. You can feel better without feeling stoned. While that will be disappointing to some, people enduring a variety of ailments may find relief, proponents and some studies say. From inflammation to pain to anxiety. From arthritis to alcoholism to diabetes. From psychoses to seizures. Cannabidiol may cure what ails you. And in many cases the science is there, even studies sponsored by the government, say the folks at Project CBD. While the regulations vary from state to state, and the definitions can be confusing, clarity is coming for at least the hemp-derived variety of products – as opposed to its sister cannabis plant, marijuana – with the likely passage of Senate Majority Leader Mitch McConnell’s Hemp Farm Bill. The measure is also noteworthy because it has drawn rare bipartisan support. CBD can be found in just about anything, from skin care products to pain medications to anti-seizure drugs—even beer. Companies, including large retailers, like Target, have tried to sell or are selling products containing CBD online or across state lines. While small compared to the marijuana industry, CBD is on a serious growth trajectory. “Spending on legal cannabis worldwide is expected to hit $57 billion by 2027,” according to an article at Forbes.com, written by Thomas Pellechia, citing the research of Arcview Market Research and BDS Analytics. “The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later.” In a release from MarketNewsUpdates.com, “A new report by cannabis/legal marijuana market analysts firm Hemp Business Journal projects that the U.S. CBD market will grow to $2.1 billion by 2020, an astronomical jump in value compared to last year's CBD market of $202 million. [...]
CBD: Legal or Not? | Webinar | Aug. 16, 2018 | 2pm
[two-fifths-first] DATE: Thursday, Aug. 16, 2018 TIME: 2 p.m. EDT; 1 p.m. CDT; 12 p.m. MDT; 11 a.m. PDT PLACE: Your computer PRICE: $197 per dial-in site (unlimited attendance at one location) through Aug. 3, $247 thereafter Register by Aug. 3 and save! For more information, email leslie.davidson@litigationconferences.com. Your webinar registration includes: • A site license to attend this webinar (invite as many people in one location as you can fit around your computer at no extra charge). • Downloadable PowerPoint presentations from our speakers. • The opportunity to connect directly with speakers during the audience Q&A session. • At least one-hour of CLE credit. Speakers Daniel Shortt Harris Bricken Seattle Alison Malsbury Harris Bricken San Francisco [/two-fifths-first][three-fifths] With so many studies coming out on the benefits of CBD, a lot of people and companies see tremendous market opportunities and are diving in. Whether derived from industrial hemp or marijuana, these days CBD can be found in just about anything, from skin care products to pain medications to anti-seizure drugs—even beer. Companies, including large retailers like Target, have tried to sell or are selling products containing CBD online or across state lines. But determining the legal status of CBD isn’t easy. Because CBD is a cannabis derivative, the biggest question, of course, is whether or not it’s even legal under state and federal law. How you answer that could mean the difference between significant revenue gains and significant losses—even the possibility of criminal prosecution—for your clients. So, what do current federal laws say about the use of CBD? How do individual state regulations affect the legal status of CBD? What do the 2014 Federal Farm Bill and the Controlled Substances Act say about growing hemp? And what are the legal and business implications for companies operating in this [...]
California Enacts the ‘First Truly Sweeping Privacy Regime’ in Record Time
The California legislature -- apparently not wanting to be pegged as just another slow-moving governing body -- took the California Consumer Privacy Act of 2018 from proposal to passage to signing in one week. Critics weren't sitting on their hands either. "Businesses Blast California’s New Data-Privacy Law," read one headline in the Wall Street Journal. For consumers, Californians anyway, the good news is that they can refuse to allow companies to sell their personal data. But, the WSJ reported, business across the country say the law will cause "far-reaching damage to everything from retailers’ customer-loyalty programs to data gathering by Silicon Valley tech giants." Law firms are cranking out their advisories and analyses. Sullivan & Cromwell says the CCPA establishes a new privacy framework for covered businesses by: "Creating an expanded definition of personal information for purposes of the Act; "Creating new data privacy rights for California consumers, including rights to know, access, have deleted and opt out of the sale of their personal information; "Imposing special rules for the collection of consumer data from minors; and "Creating a new and potentially severe statutory damages framework for violations of the Act and for businesses that fail to implement reasonable security procedures and practices to prevent data breaches." The firm also offered a quick comparison between the CCPA and the GDPR. "At a high level, the CCPA bears certain similarities to GDPR, the comprehensive regulation governing the “processing of personal data” of EU residents. But the CCPA and GDPR provide for differing rights, obligations, and exceptions, and compliance with one will not necessarily ensure compliance with the other. For example, unlike GDPR, the CCPA does not generally (other than with respect to minors) require businesses to implement an “opt-in” system to obtain consumers’ consent prior to processing their information. Instead, the [...]
Complex Post-Settlement Liens | Webinar | July 26, 2018 | 2pm
[two-fifths-first] Date: July 26, 2018 Time: 2pm-3:30pm Fee: $125 Register and pay online or contact Kathleen.McFadden@LitigationConferences.com (484) 324-2755 x2000 Speakers Franklin Solomon Solomon Law Firm Brett Newman Lien Resolution Group [/two-fifths-first] [three-fifths] Complex Post-Settlement Liens Join us for a highly practical session with two deeply experienced practitioners who will share their insights and answer your questions on issues that impact the cases on your desk today. Learn about the newest case law, agency positions and litigation tactics affecting health and disability plan reimbursement claims, including how to protect your clients and your practice in this rapidly developing area. Our speakers will discuss: Medicare Advantage Plans Federal Employees Health Benefits Act (FEHBA) Plans Employee Retirement Income Security Act (ERISA) Claims Medicare set-asides TRICARE Veterans Administration Claims Speaker Bios Franklin P. Solomon | Solomon Law Firm Franklin Solomon has a nationwide practice focused on evaluation, litigation and resolution of healthcare lien/reimbursement claims. He represents personal injury victims and their attorneys in defending against claims by health plans and government benefits programs seeking payment out of tort recoveries. Most recently, he was plaintiffs’ counsel in two federal appellate court cases decided last summer: Wurtz v. The Rawlings Company, ___ F.3d ___, (2d Cir. 2014), a class action challenging New York insurers’ reimbursement claims against their insureds, and Taransky v. Sec. U.S. Dept. of Health & Human Svcs., ___ F.3d ___ (3d Cir. 2014), a class action challenging Medicare’s claims for reimbursement out of New Jersey tort recoveries. Brett Newman | The Lien Resolution Group Brett Newman is known nationally by plaintiff attorneys for his expertise on claims avoidance and reduction. Recognizing the ever-growing nature of lien resolution and the ever-increasing associated liability, Brett established The Lien Resolution Group and The Newman Structured Settlement Group to assist both individual claimants of personal [...]
Congressional Cannabis Proposal Would Can Criminalization
Could this be the thing that brings the parties together? Here is a quote from an article written for Forbes.com by freelance writer Janet Burns. [Jolene Forman, staff attorney at the nonprofit Drug Policy Alliance] called the bill a "first step," and noted, “This bipartisan proposal clears the way for states to develop their own marijuana policies without fear of federal intervention. This will give states more opportunity to restore communities that have borne the brunt of the drug war and mass criminalization." So far, 30 states, Washington, DC and the U.S. territories of Guam and Puerto Rico have enacted medical marijuana legislation, while estimates suggest that 63 million Americans reside in areas where anyone over 21 may now legally possess the plant.
Miller Friel: Opioid Suppliers Are Right to Expect Insurance Coverage
An excerpt from a post by Bernard Bell of Miller Friel PLLC "Because insurers are facing a difficult time evading coverage for opioid claims, they are raising all sorts of non-contractual defenses to avoid coverage, including a 'social insurance' argument they have raised in the past. "If past public health crises are prologue, these arguments will run something like this: Holding insurers responsible to pay for the costs of public services, including health care, will transform private party liability insurance into social insurance to underwrite public health epidemics caused by all manner of ills. According to insurers, this will, at a minimum, increase the cost of liability insurance, and financially harm liability insurers, who have not priced this risk into their premiums. Moreover, holding insurers liable to pay will shift costs away from those best equipped to address the social problem; the companies that supply the opioid products. "These arguments are inconsistent with insurance law, which permits parties to freely contract to cover risks, and which place the burden on insurers to pay for insured risk, even if they made an error in underwriting. Courts interpret insurance contracts according to their language and construe them against insurers if they are ambiguous, and in favor of an insureds’ reasonable expectations of coverage. "Moreover, to the extent courts are inclined to look past contract language when construing insurance policies, the social arguments cut in favor of coverage, not against it, because liability insurance is designed to perform risk management, and deterrence and compensation functions of insurance are important to the social functioning and ordering of society. ... These social purposes are especially easy to grasp in the context of pharmaceutical companies that develop and bring to market countless products, including opioid pain medicine, that can relieve human pain and suffering. These companies [...]
Insurance Coverage and GDPR: What’s Your Financial Exposure? –Linda Kornfeld, Blank Rome
In her recent article -- GDPR Is Finally Here: It’s Time to Make Sure Your Current Cyber Policy Will Protect against New Financial Exposures -- Blank Rome insurance coverage partner Linda Kornfeld wrote: Companies can face large financial exposure for GDPR “fines or penalties.” Are they covered under currently worded cyber policies? The answer is, maybe not if your policy, e.g., covers regulatory proceedings addressing only failures to protect private information, as opposed to GDPR proceedings that may address broader noncompliant data collection and use practices. Additionally, coverage for GDPR fines or penalties may be more restricted under the laws of many European countries than the laws of certain states in the United States. Your insurer may agree to choice of law language in your policy that will increase the chances of coverage. On behalf of all of us at HB -- Congratulations to Linda on her move to Blank Rome! Now Vice Chair of the firm's Insurance Recovery Practice Group, Linda is one of the nation’s most prominent insurance recovery attorneys, representing corporate policyholders in high-stakes litigation for more than 25 years. Using strategic, creative approaches in her trial and appellate practice, Linda assists her clients in the recovery of hundreds of millions of dollars in insurance assets. She is a strategic adviser to senior executives and in-house counsel on mitigating risk and maximizing insurance recoveries. Linda has been a valued contributor to HB programs and, before that, to Mealey's Conferences and Mealey's Litigation Reports.
Class Actions Weekly Roundup from Top Class Actions
This roundup is prepared exclusively for HB Litigation Conferences by: Walmart Class Action Claims Glucosamine Tablets are Mislabeled Walmart has been hit with a class action lawsuit claiming that their store brand glucosamine tablets are mislabeled. Plaintiffs Cynthia Parker, Reba Garth, Margaret Herrin, and Shirley Reinhard allege that Walmart misrepresents its store-brand glucosamine sulfate dietary… Read More Sorin 3T Heater Cooler Lawsuit Alleges Serious M. Chimaera Bacterial Infection An Indiana man has filed a Sorin 3T heater cooler lawsuit against LivaNova PLC, alleging their cardiac heater cooler device had caused him to develop a potentially fatal infection. The claimant filed the Sorin 3T heater cooler… Read More Coca-Cola Seeks Dismissal of Diet Coke Class Action Lawsuit Coca-Cola asked a New York federal court to toss a class action lawsuit alleging the company’s use of the name “Diet Coke” is misleading. The company argues that claims against its use of the word “diet” in… Read More Couple Files Stryker Hip Recall Lawsuit Over Metallosis Complications Thousands of hip implants were affected by a Stryker hip recall after they were linked with serious complications, including metallosis. Some patients affected by these major side effects have turned to litigation, hoping to regain some… Read More Facebook Class Action Challenges Facial Recognition Technology Facebook faces a new class action lawsuit alleging that the social media site captured and stored biometric information of non-users in violation of Illinois state law. Plaintiff Clayton Zellmer argues that Facebook broke state law by… Read More Woman Alleges Bleeding While Taking Xarelto in Lawsuit Against Drug Makers A woman who allegedly suffered bleeding while taking Xarelto has filed a lawsuit against the makers of the anticoagulant drug. Plaintiff Emmy L. filed the Xarelto lawsuit in Louisiana federal court, joining a growing multidistrict litigation (MDL) against… Read More Arthrex Knee Replacement Causes Injuries, Patients Claim Knee replacement surgery is one [...]
Top Class Actions’ Top Trends Affecting Class Actions in 2018
Editor's Note: This article was written by Kim Gale at Top Class Actions and is reprinted here with the permission of the publisher. Scott Hardy, the company's President & CEO, is one of the speakers featured at HB's Class Action Mastery conference May 9-11, 2018 in New York. Top Class Actions is sponsoring that event and its companion program, Mass Tort Med School, the same week. As we come close to rounding out the first quarter of 2018, it is clear that several class action lawsuit trends from 2017 will continue to ripple through the court system this year. Class Action Lawsuit Stats Did you know three areas are responsible for a third of all class action lawsuits filed in the U.S.? The federal courts in California, Southern District (Miami) of Florida, and the Eastern District (Brooklyn) of New York keep lawyers and judges the busiest. In the initial nine months of 2017, a total 3,136 federal class action lawsuits were filed in those areas alone, according to an article published Dec. 9, 2017 by PorterWright.com. These statistics are apt to change because new Supreme Court decisions (Bristol-Myers Squibb v. Superior Court of California and BNSF Railway Co. v. Tyrrell) rein in a court’s jurisdiction and ability to litigate matters when residents from outside the court’s state make claims. These new decisions mean a defendant will need to be sued in the state where the business is incorporated. Another option could be for individual states to file class action lawsuits and then seek to have them consolidated through multidistrict litigation (MDL). Marketing Tactics Under Fire Makers of everything from washing machines to mascara faced allegations of product misrepresentation. Advertising claims such as “organic,” “preservative free” and “virgin” can land a company in hot water with multiple class action lawsuits if these claims [...]